Show simple item record

Biliary complications following liver transplantation in the model for end-stage liver disease era: Effect of donor, recipient, and technical factors

dc.contributor.authorWelling, Theodore H.en_US
dc.contributor.authorHeidt, David G.en_US
dc.contributor.authorEnglesbe, Michael J.en_US
dc.contributor.authorMagee, John C.en_US
dc.contributor.authorSung, Randall S.en_US
dc.contributor.authorCampbell, Darrell A.en_US
dc.contributor.authorPunch, Jeffrey D.en_US
dc.contributor.authorPelletier, Shawn J.en_US
dc.date.accessioned2008-01-04T20:11:49Z
dc.date.available2009-01-07T20:01:15Zen_US
dc.date.issued2008-01en_US
dc.identifier.citationWelling, Theodore H.; Heidt, David G.; Englesbe, Michael J.; Magee, John C.; Sung, Randall S.; Campbell, Darrell A.; Punch, Jeffrey D.; Pelletier, Shawn J. (2008). "Biliary complications following liver transplantation in the model for end-stage liver disease era: Effect of donor, recipient, and technical factors." Liver Transplantation 14(1): 73-80. <http://hdl.handle.net/2027.42/57538>en_US
dc.identifier.issn1527-6465en_US
dc.identifier.issn1527-6473en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/57538
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18161843&dopt=citationen_US
dc.description.abstractBiliary complications remain a significant problem following liver transplantation in the Model for End-Stage Liver Disease (MELD) era. We hypothesized that donor, recipient, and technical variables may differentially affect anastomotic biliary complications in MELD era liver transplants. We reviewed 256 deceased donor liver transplants after the institution of MELD at our center and evaluated these variables' association with anastomotic biliary complications. The bile leak rate was 18%, and the stricture rate was 23%. Univariate analysis revealed that recipient age, MELD, donor age, and warm ischemia were risk factors for leak, whereas a Roux limb or stent was protective. A bile leak was a risk factor for anastomotic stricture, whereas use of histidine tryptophan ketoglutarate (HTK) versus University of Wisconsin (UW) solution was protective. Additionally, use of a transcystic tube/stent was also protective. Multivariate analysis showed that warm ischemia was the only independent risk factor for a leak, whereas development of a leak was the only independent risk factor for a stricture. HTK versus UW use and transcystic tube/stent use were the only independent protective factors against stricture. Use of an internal stent trended in the multivariate analysis toward being protective against leaks and strictures, but this was not quite statistically significant. This represents one of the first MELD era studies of deceased donor liver transplants evaluating factors affecting the incidence of anastomotic bile leaks and strictures. Donor, recipient, and technical factors appear to differentially affect the incidence of anastomotic biliary complications, with warm ischemia, use of HTK, and use of a stent emerging as the most important variables. Liver Transpl 14:73–80, 2008. © 2007 AASLD.en_US
dc.format.extent104246 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherSurgeryen_US
dc.titleBiliary complications following liver transplantation in the model for end-stage liver disease era: Effect of donor, recipient, and technical factorsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Transplantation, University of Michigan Medical Center, Ann Arbor, MI ; Telephone: 734-936-8363; FAX: 734-763-3187 ; 1500 East Medical Center Drive, 2926 Taubman Center, Ann Arbor, MI 48109en_US
dc.contributor.affiliationumDivision of Transplantation, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationumDivision of Transplantation, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationumDivision of Transplantation, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationumDivision of Transplantation, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationumDivision of Transplantation, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationumDivision of Transplantation, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationumDivision of Transplantation, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.identifier.pmid18161843en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/57538/1/21354_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/lt.21354en_US
dc.identifier.sourceLiver Transplantationen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.